Intratumor heterogeneity defines treatment‐resistant <scp>HER</scp> 2+ breast tumors
Inga Hansine Rye(Oslo University Hospital), Hege G. Russnes(Oslo University Hospital), Kornélia Polyák(Dana-Farber Cancer Institute), Vanessa Almendro(Danaher (United States)), Anne Trinh(Brigham and Women's Hospital), Ole Christian Lingjærde(Oslo University Hospital), Daniel Nebdal(Oslo University Hospital), Åslaug Helland(Oslo University Hospital), Anna Barbro Sætersdal(Oslo University Hospital), Florian Markowetz(Cancer Research UK), Anne‐Lise Børresen‐Dale(Oslo University Hospital)
Cited by 102
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
|Nature reviews. Cancer|2009|3.3k
The Genomic Landscapes of Human Breast and Colorectal Cancers
|Science|2007|2.8k